- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2012 (2012), Article ID 926857, 8 pages
The Genetics of PTPN1 and Obesity: Insights from Mouse Models of Tissue-Specific PTP1B Deficiency
Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Vet 223E, Philadelphia, PA 19104, USA
Received 24 February 2012; Revised 18 April 2012; Accepted 18 April 2012
Academic Editor: Yvon Chagnon
Copyright © 2012 Ryan C. Tsou and Kendra K. Bence. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. S. Ahima, “Obesity epidemic in need of answers,” Gastroenterology, vol. 131, no. 4, p. 991, 2006.
- K. M. Flegal, M. D. Carroll, B. K. Kit, and C. L. Ogden, “Prevalence of obesity and trends in the distribution of body mass index among US adults,” The Journal of the American Medical Association, vol. 307, no. 5, pp. 491–497, 2012.
- M. Elchebly, P. Payette, E. Michaliszyn et al., “Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene,” Science, vol. 283, no. 5407, pp. 1544–1548, 1999.
- L. D. Klaman, O. Boss, O. D. Peroni et al., “Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice,” Molecular and Cellular Biology, vol. 20, no. 15, pp. 5479–5489, 2000.
- J. M. Zabolotny, K. K. Bence-Hanulec, A. Stricker-Krongrad et al., “PTP1B regulates leptin signal transduction in vivo,” Developmental Cell, vol. 2, no. 4, pp. 489–495, 2002.
- A. Cheng, N. Uetani, P. D. Simoncic et al., “Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B,” Developmental Cell, vol. 2, no. 4, pp. 497–503, 2002.
- S. Brown-Shimer, K. A. Johnson, J. B. Lawrence et al., “Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 13, pp. 5148–5152, 1990.
- A. Lembertas, L. Pérusse, Y. C. Chagnon et al., “Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q,” The Journal of Clinical Investigation, vol. 100, no. 5, pp. 1240–1247, 1997.
- S. Ghosh, R. M. Watanabe, E. R. Hauser et al., “Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2198–2203, 1999.
- J. H. Lee, D. R. Reed, W.-D. Li, et al., “Genome scan for human obesity and linkage to markers in 20q13,” The American Journal of Human Genetics, vol. 64, no. 1, pp. 196–209, 1999.
- S. Kipfer-Coudreau, D. Eberlé, M. Sahbatou et al., “Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects,” Diabetologia, vol. 47, no. 7, pp. 1278–1284, 2004.
- C. Cheyssac, C. Lecoeur, A. Dechaume et al., “Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population,” BMC Medical Genetics, vol. 7, article 44, 2006.
- O. Ukkola, T. Rankinen, T. Lakka et al., “Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism,” Obesity Research, vol. 13, no. 5, pp. 829–834, 2005.
- J. Mo, J. Wu, Z. Sun, H. Yang, M. Lei, and W. Liu, “Association of PTP1B gene polymorphism with obesity in Chinese children,” Journal of Central South University, vol. 35, no. 9, pp. 915–920, 2010.
- R. D. Poala, L. Frittitta, G. Miscio, et al., “A variation in 3' UTR of hPTP1b increases specific gene expression and associates with insulin resistance,” The American Journal of Human Genetics, vol. 70, no. 3, pp. 806–812, 2002.
- R. Meshkani, M. Taghikhani, A. Mosapour et al., “1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population,” Archives of Medical Research, vol. 38, no. 5, pp. 556–562, 2007.
- N. D. Palmer, J. L. Bento, J. C. Mychaleckyj et al., “Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study,” Diabetes, vol. 53, no. 11, pp. 3013–3019, 2004.
- S. M. Echwald, H. Bach, H. Vestergaard et al., “A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro,” Diabetes, vol. 51, no. 1, pp. 1–6, 2002.
- F. Bauer, O. M. Charlotte, A. G. Niehoff et al., “PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, no. 1, pp. 28–34, 2010.
- K. P. Burdon, J. L. Bento, C. D. Langefeld et al., “Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the diabetes heart study,” Diabetes, vol. 55, no. 3, pp. 651–658, 2006.
- M. Olivier, C. A. Hsiung, L. M. Chuang et al., “Single nucleotide polymorphisms in protein tyrosine phosphatase 1β (PTPN1) are associated with essential hypertension and obesity,” Human Molecular Genetics, vol. 13, no. 17, pp. 1885–1892, 2004.
- W.-C. Wang, C. A. Hsiung, L.-C. Wang, L.-M. Chuang, T. Quertermous, and I.-S. Chang, “Distribution of the number of false discoveries in large-scale family-based association testing with application to the association between PTPN1 and hypertension and obesity,” Human Genetics, vol. 129, no. 4, pp. 425–432, 2011.
- D. W. Bowden, “Association of the PTPN1 gene with type 2 diabetes and insulin resistance,” Discovery Medicine, vol. 4, no. 24, pp. 427–432, 2004.
- A. Mok, H. Cao, B. Zinman et al., “A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in oji-cree,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 724–727, 2002.
- T. Klupa, M. T. Malecki, M. Pezzolesi et al., “Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2,” Diabetes, vol. 49, no. 12, pp. 2212–2216, 2000.
- J. L. Bento, N. D. Palmer, J. C. Mychaleckyj et al., “Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes,” Diabetes, vol. 53, no. 11, pp. 3007–3012, 2004.
- N. J. Spencer-Jones, X. Wang, H. Snieder, T. D. Spector, N. D. Carter, and S. D. O'Dell, “Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population,” Diabetes, vol. 54, no. 11, pp. 3296–3304, 2005.
- F. Bauer, N. C. Onland-Moret, A. G. Niehoff et al., “No association of PTPN1 polymorphisms with macronutrient intake and measures of adiposity,” Obesity, vol. 16, no. 12, pp. 2767–2771, 2008.
- M. Traurig, R. L. Hanson, S. Kobes, C. Bogardus, and L. J. Baier, “Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among pima Indians,” Diabetologia, vol. 50, no. 5, pp. 985–989, 2007.
- D. Bodhini, V. Radha, S. Ghosh, P. P. Majumder, and V. Mohan, “Lack of association of PTPN1 gene polymorphisms with type 2 diabetes in South Indians,” Journal of Genetics, vol. 90, no. 2, pp. 323–326, 2011.
- I. Dahlman, H. Wahrenberg, L. Persson, and P. Arner, “No association of reported functional protein tyrosine phosphatase 1B 3' UTR gene polymorphism with features of the metabolic syndrome in a Swedish population,” Journal of Internal Medicine, vol. 255, no. 6, pp. 694–695, 2004.
- R. Di Paola, V. Tassi, and V. Trischitta, “Reply to Dahlman et al. No association of reported functional protein tyrosine phosphatase 1B 3'UTR gene polymorphism with features of the metabolic syndrome in a Swedish population. Journal of Internal Medicine 2004; 255: 694–695,” Journal of Internal Medicine, vol. 258, no. 3, pp. 289–290, 2005.
- N. K. Tonks, “Protein tyrosine phosphatases: from genes, to function, to disease,” Nature Reviews Molecular Cell Biology, vol. 7, no. 11, pp. 833–846, 2006.
- M. F. Cicirelli, N. K. Tonks, C. D. Diltz, J. E. Weiel, E. H. Fischer, and E. G. Krebs, “Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 14, pp. 5514–5518, 1990.
- B. J. Goldstein, “Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance,” Current Drug Targets—Immune, Endocrine & Metabolic Disorders, vol. 1, no. 3, pp. 265–275, 2001.
- E. Asante-Appiah and B. P. Kennedy, “Protein tyrosine phosphatases: the quest for negative regulators of insulin action,” American Journal of Physiology, vol. 284, no. 4, pp. E663–E670, 2003.
- A. Bourdeau, N. Dubé, and M. L. Tremblay, “Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP,” Current Opinion in Cell Biology, vol. 17, no. 2, pp. 203–209, 2005.
- C. Bjørbaek and B. B. Kahn, “Leptin signaling in the central nervous system and the periphery,” Recent Progress in Hormone Research, vol. 59, pp. 305–331, 2004.
- Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994.
- M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995.
- G. H. Lee, R. Proenca, J. M. Montez et al., “Abnormal splicing of the leptin receptor in diabetic mice,” Nature, vol. 379, no. 6566, pp. 632–635, 1996.
- M. G. Myers, M. A. Cowley, and H. Münzberg, “Mechanisms of leptin action and leptin resistance,” Annual Review of Physiology, vol. 70, pp. 537–556, 2008.
- M. G. Myers, R. L. Leibel, R. J. Seeley, and M. W. Schwartz, “Obesity and leptin resistance: distinguishing cause from effect,” Trends in Endocrinology and Metabolism, vol. 21, no. 11, pp. 643–651, 2010.
- M. P. Myers, J. N. Andersen, A. Cheng et al., “TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B,” The Journal of Biological Chemistry, vol. 276, no. 51, pp. 47771–47774, 2001.
- K. K. Bence, M. Delibegovic, B. Xue et al., “Neuronal PTP1B regulates body weight, adiposity and leptin action,” Nature Medicine, vol. 12, no. 8, pp. 917–924, 2006.
- R. Banno, D. Zimmer, B. C. De Jonghe et al., “PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice,” The Journal of Clinical Investigation, vol. 120, no. 3, pp. 720–734, 2010.
- R. L. Leshan, M. Björnholm, H. Münzberg, and M. G. Myers, “Leptin receptor signaling and action in the central nervous system,” Obesity, vol. 14, supplement 5, pp. 208S–212S, 2006.
- M. Delibegovic, K. K. Bence, N. Mody et al., “Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B,” Molecular and Cellular Biology, vol. 27, no. 21, pp. 7727–7734, 2007.
- M. Delibegovic, D. Zimmer, C. Kauffman et al., “Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress,” Diabetes, vol. 58, no. 3, pp. 590–599, 2009.
- C. Owen, A. J. Czopek, A. Agouni, et al., “Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis,” PloS ONE, vol. 7, no. 2, 2012.
- A. Agouni, N. Mody, C. Owen, et al., “Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress,” The Biochemical Journal, vol. 438, no. 2, pp. 369–378, 2011.
- Z. Wang, Y. Deng, Q. Wang, K. Sun, and P. E. Scherer, “Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression,” Endocrinology, vol. 151, no. 6, pp. 2933–2939, 2010.
- J. Mao, T. Yang, Z. Gu et al., “AP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 41, pp. 17576–17581, 2009.
- J. Eguchi, X. Wang, S. Yu et al., “Transcriptional control of adipose lipid handling by IRF4,” Cell Metabolism, vol. 13, no. 3, pp. 248–259, 2011.
- H. Slomko, H. Heo, and F. Einstein, “Minireview: epigenetics of obesity and diabetes in humans,” Endocrinology, vol. 153, no. 3, pp. 1025–1030, 2012.
- J. M. Zabolotny, Y.-B. Kim, L. A. Welsh, E. E. Kershaw, B. G. Neel, and B. B. Kahn, “Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14230–14241, 2008.
- C. L. White, A. Whittington, M. J. Barnes, Z. Wang, G. A. Bray, and C. D. Morrison, “HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms,” American Journal of Physiology, vol. 296, no. 2, pp. E291–E299, 2009.
- P. K. Picardi, A. M. Caricilli, L. L. F. D. Abreu, J. B. C. Carvalheira, L. A. Velloso, and M. J. A. Saad, “Modulation of hypothalamic PTP1B in the TNF-α-induced insulin and leptin resistance,” FEBS Letters, vol. 584, no. 14, pp. 3179–3184, 2010.
- Y. Ito, R. Banno, S. Hagimoto, Y. Ozawa, H. Arima, and Y. Oiso, “TNFα increases hypothalamic PTP1B activity via the NFκB pathway in rat hypothalamic organotypic cultures,” Regulatory Peptides, vol. 174, no. 1–3, pp. 58–64, 2012.
- I. Nieto-Vazquez, S. Fernández-Veledo, C. de Alvaro, and M. Lorenzo, “Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle,” Diabetes, vol. 57, no. 12, pp. 3211–3221, 2008.
- L. Ozcan, A. S. Ergin, A. Lu et al., “Endoplasmic reticulum stress plays a central role in development of leptin resistance,” Cell Metabolism, vol. 9, no. 1, pp. 35–51, 2009.